Progress in aorta and peripheral cardiovascular disease research.


Journal

Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427

Informations de publication

Date de publication:
27 07 2021
Historique:
received: 16 01 2021
revised: 02 03 2021
accepted: 20 04 2021
pubmed: 24 4 2021
medline: 12 8 2021
entrez: 23 4 2021
Statut: ppublish

Résumé

Although coronavirus disease 2019 seems to be the leading topic in research number of outstanding studies have been published in the field of aorta and peripheral vascular diseases likely affecting our clinical practice in the near future. This review article highlights key research on vascular diseases published in 2020. Some studies have shed light in the pathophysiology of aortic aneurysm and dissection suggesting a potential role for kinase inhibitors as new therapeutic options. A first proteogenomic study on fibromuscular dysplasia (FMD) revealed a promising novel disease gene and provided proof-of-concept for a protein/lipid-based FMD blood test. The role of NADPH oxidases in vascular physiology, and particularly endothelial cell differentiation, is highlighted with potential for cell therapy development. Imaging of vulnerable plaque has been an intense field of research. Features of plaque vulnerability on magnetic resonance imaging as an under-recognized cause of stroke are discussed. Major clinical trials on lower extremity peripheral artery disease have shown added benefit of dual antithrombotic (aspirin plus rivaroxaban) treatment.

Identifiants

pubmed: 33892507
pii: 6248085
doi: 10.1093/cvr/cvab144
pmc: PMC8600478
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2045-2053

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Références

Cardiovasc Res. 2021 Feb 22;117(3):942-949
pubmed: 32289159
J Clin Oncol. 2018 Jul 10;36(20):2017-2023
pubmed: 29746227
J Am Coll Cardiol. 2020 Nov 10;76(19):2212-2222
pubmed: 33153580
Eur Heart J. 2020 Aug 14;41(31):2938-2948
pubmed: 32728688
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
Cardiovasc Res. 2020 Dec 1;116(14):2177-2184
pubmed: 32750108
Eur Heart J. 2020 Jul 7;41(26):2442-2453
pubmed: 32428930
J Clin Invest. 2020 Feb 3;130(2):686-698
pubmed: 31639107
Cardiovasc Res. 2020 Dec 1;116(14):2226-2238
pubmed: 31710686
N Engl J Med. 2020 Apr 23;382(17):1599-1607
pubmed: 32223112
PLoS One. 2020 Aug 26;15(8):e0238215
pubmed: 32845926
Cardiovasc Res. 2020 Aug 1;116(10):1767-1778
pubmed: 31800011
Heart. 2020 Jun;106(12):892-897
pubmed: 32152004
Eur Heart J. 2014 Nov 1;35(41):2873-926
pubmed: 25173340
Cardiovasc Res. 2020 Feb 1;116(2):262-268
pubmed: 31393561
Cardiovasc Res. 2020 Jan 1;116(1):63-77
pubmed: 31424497
Circulation. 2020 Sep 8;142(10):920-928
pubmed: 32580567
Eur Heart J. 2020 May 1;41(17):1636-1649
pubmed: 31883328
Ann Vasc Surg. 2020 Jan;62:133-141
pubmed: 31494265
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
Am J Cardiol. 2018 May 1;121(9):1094-1101
pubmed: 29631804
J Am Coll Cardiol. 2020 Jul 14;76(2):201-217
pubmed: 32646571
Cardiovasc Res. 2020 Feb 1;116(2):450-456
pubmed: 31135888
Circulation. 2020 May 19;141(20):1600-1607
pubmed: 32223429
J Am Coll Cardiol. 2019 Oct 15;74(15):1883-1894
pubmed: 31526537
JACC Cardiovasc Imaging. 2021 Aug;14(8):1614-1624
pubmed: 33221224
J Am Coll Cardiol. 2020 Oct 20;76(16):1862-1874
pubmed: 33059832
Cardiovasc Res. 2020 Feb 1;116(2):393-405
pubmed: 30937452
J Thromb Haemost. 2020 Feb;18(2):411-421
pubmed: 31630479
N Engl J Med. 2018 Feb 15;378(7):615-624
pubmed: 29231094
Eur Heart J Cardiovasc Pharmacother. 2020 Apr 1;6(2):86-93
pubmed: 31392312
N Engl J Med. 2020 Dec 24;383(26):2538-2546
pubmed: 33296560
J Am Coll Cardiol. 2020 Feb 18;75(6):608-617
pubmed: 32057375
Circulation. 2020 May 19;141(20):1608-1617
pubmed: 32223446
N Engl J Med. 2020 May 21;382(21):1994-2004
pubmed: 32222135
Cardiovasc Res. 2020 Apr 1;116(5):908-915
pubmed: 31746997
J Am Heart Assoc. 2018 Dec 18;7(24):e011245
pubmed: 30561254
JAMA Cardiol. 2020 Dec 1;5(12):1374-1381
pubmed: 32845283
Chest. 2021 Mar;159(3):1182-1196
pubmed: 33217420
Eur J Vasc Endovasc Surg. 2020 Oct;60(4):602-612
pubmed: 32709465
Cardiovasc Res. 2020 Sep 1;116(11):1918-1924
pubmed: 31807773
Diabetes Care. 2020 Jul;43(7):1520-1529
pubmed: 32358022

Auteurs

Lucia Mazzolai (L)

Division of Angiology, Heart and Vessel Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Adriano Alatri (A)

Division of Angiology, Heart and Vessel Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Alessandra Bura Rivière (AB)

Division of Vascular Medicine, Heart, Vessels and Metabolisms Department, Toulouse University Hospital, Toulouse, France.

Marco De Carlo (M)

Cardiothoracic and Vascular Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

Christian Heiss (C)

Department of Clinical and Experimental Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford GU2 7XH, UK.

Christine Espinola-Klein (C)

Section Angiology, Department of Cardiology, Cardiology I, University Medical Center Mainz, Mainz, Germany.

Oliver Schlager (O)

Division of Angiology, Department of Medicine II, Medical University of Vienna, Waehringer Gürtel 18-20, 1090 Vienna, Austria.

Henrik Sillesen (H)

Department of Vascular Surgery, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Daniel Staub (D)

Division of Angiology, University Hospital Basel, University of Basel, Basel, Switzerland.

José F Rodriguez-Palomares (JF)

Cardiology Department, Hospital General Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), CIBER-CV, Barcelona, Spain.

Aline Verstraeten (A)

Centre of Medical Genetics, Faculty of Medicine and Health Sciences, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium.

Victor Aboyans (V)

Department of Cardiology, Dupuytren-2 University Hospital, and Inserm 1094 & IRD, Limoges University, Limoges, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH